MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Integra Lifesciences Holdings Corp Company Profile (NASDAQ:IART)

Consensus Ratings for Integra Lifesciences Holdings Corp (NASDAQ:IART) (?)
Ratings Breakdown: 3 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $69.67 (15.09% upside)

Current Analysts' Coverage Summary for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2015Jefferies GroupReiterated RatingBuy$67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015OppenheimerSet Price TargetBuy$76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2015BarclaysBoost Price TargetEqual Weight$63.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015RBC CapitalBoost Price TargetSector Perform$62.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Lake Street CapitalDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015ArgusBoost Price TargetBuy$61.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2015Piper JaffrayInitiated CoverageOverweight$67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2014Bank of AmericaUpgradeUnderperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2013Morgan StanleyUpgradeUnderweight -> Equal Weight$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/5/2013 forward)